EOLS

Evolus Stock Analysis

AI Rating

Neutral
  • Quality0/10
  • Growth 6/10
  • Value 2/10
Evolus sales and earnings growth
EOLS Growth
Good
  • Revenue Y/Y 7.08%
  • EPS Y/Y 23.86%
  • FCF Y/Y -55.23%
Evolus gross and profit margin trends
EOLS Profitability
Good
  • Gross margin 66.10%
  • EPS margin -14.40%
  • ROIC 5Y -30.30%
Evolus net debt vs free cash flow
EOLS Risk
Great
  • Debt / Equity 0.0
  • Debt / FCF 2.6
  • Interest coverage -1.2

Evolus stock volatility is in-line with the overall market. We give it a Great risk rating.

↗ More Drug Manufacturers - Specialty & Generic stocks